OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence
Di Fu, Hong‐Li Guo, Ya‐Hui Hu, et al.
European Journal of Clinical Pharmacology (2023)
Closed Access | Times Cited: 6
Di Fu, Hong‐Li Guo, Ya‐Hui Hu, et al.
European Journal of Clinical Pharmacology (2023)
Closed Access | Times Cited: 6
Showing 6 citing articles:
In silico molecular docking and in vitro analysis of atomoxetine
Nurullah Bolat, Meliha Merve Hız, Erhan Akıncı, et al.
Drug and Chemical Toxicology (2025), pp. 1-9
Closed Access
Nurullah Bolat, Meliha Merve Hız, Erhan Akıncı, et al.
Drug and Chemical Toxicology (2025), pp. 1-9
Closed Access
Atomoxetine Treatment of Attention Deficit/Hyperactivity Disorder Symptoms in 3–6-Year-Old Children with Autism Spectrum Disorder: A Retrospective Cohort Study
Hamza A. Alsayouf, Osama Alsarhan, Wael Khreisat, et al.
Children (2024) Vol. 11, Iss. 2, pp. 163-163
Open Access | Times Cited: 3
Hamza A. Alsayouf, Osama Alsarhan, Wael Khreisat, et al.
Children (2024) Vol. 11, Iss. 2, pp. 163-163
Open Access | Times Cited: 3
Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together
Hong‐Li Guo, Dan-Dan Wu, Di Fu, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Hong‐Li Guo, Dan-Dan Wu, Di Fu, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Growing evidence of pharmacotherapy effectiveness in managing attention-deficit/hyperactivity disorder in young children with or without autism spectrum disorder: a minireview
Hamza A. Alsayouf
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Hamza A. Alsayouf
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder
İsmail Hasan Köle, Pınar IRMAK VURAL, Beste Yurdacan, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1773-1785
Closed Access
İsmail Hasan Köle, Pınar IRMAK VURAL, Beste Yurdacan, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1773-1785
Closed Access
Precision pharmacotherapy of atomoxetine in children with ADHD: how to ensure the right dose for the right person?
Hong‐Li Guo, Jian Huang, Jie Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Hong‐Li Guo, Jian Huang, Jie Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
